Drostanolone Propionate 100 - Aaster Solutions

Drostanolone propionate entered the medical field as a treatment for advanced breast cancer, where it helped reduce estrogen-driven tumor growth. Developed by Syntex and marketed in the U.S. by Eli Lilly as Drolban, it became known for its non-estrogenic, DHT-based structure. This gave it a unique ability to harden muscle without water retention. Though discontinued from pharmaceutical use, it gained long-term popularity in competitive bodybuilding, especially during the final stages of contest prep.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Drostanolone Propionate 100 by Aaster Solutions, consult with your doctor or healthcare professional.